Voriconazole pharmacogenetics - Authors' reply
- PMID: 34391493
- DOI: 10.1016/S0140-6736(21)00874-6
Voriconazole pharmacogenetics - Authors' reply
Conflict of interest statement
JAM reports grants, personal fees, and non-financial support from Merck Sharp & Dohme, a subsidiary of Merck & Co, Gilead Sciences, and Pfizer; and personal fees and non-financial support from Mundipharma, F2G, Cidara, Basilea, and Schering-Plough. HAW, RMW, and PMS are employees of Merck & Co.
Comment on
-
Voriconazole pharmacogenetics.Lancet. 2021 Aug 14;398(10300):578. doi: 10.1016/S0140-6736(21)00879-5. Lancet. 2021. PMID: 34391494 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
